Vyne Total Assets vs Accounts Payable Analysis
VYNE Stock | USD 2.97 0.40 15.56% |
Vyne Therapeutics financial indicator trend analysis is much more than just breaking down Vyne Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vyne Therapeutics is a good investment. Please check the relationship between Vyne Therapeutics Total Assets and its Accounts Payable accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vyne Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Vyne Stock refer to our How to Trade Vyne Stock guide.
Total Assets vs Accounts Payable
Total Assets vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Vyne Therapeutics Total Assets account and Accounts Payable. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Vyne Therapeutics' Total Assets and Accounts Payable is 0.54. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Vyne Therapeutics, assuming nothing else is changed. The correlation between historical values of Vyne Therapeutics' Total Assets and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Vyne Therapeutics are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Total Assets i.e., Vyne Therapeutics' Total Assets and Accounts Payable go up and down completely randomly.
Correlation Coefficient | 0.54 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Total Assets
Total assets refers to the total amount of Vyne Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Vyne Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Accounts Payable
An accounting item on the balance sheet that represents Vyne Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Vyne Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most indicators from Vyne Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vyne Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vyne Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Vyne Stock refer to our How to Trade Vyne Stock guide.At present, Vyne Therapeutics' Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 0.23, whereas Issuance Of Capital Stock is forecasted to decline to about 347.7 K.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 11.4M | 477K | 424K | 402.8K | Total Revenue | 14.8M | 477K | 424K | 402.8K |
Vyne Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Vyne Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Vyne Therapeutics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 79.2M | 93.7M | 67.0M | 40.8M | 97.7M | 82.0M | |
Other Current Liab | 485K | 15.2M | 11.2M | 7.0M | 5.6M | 5.6M | |
Total Current Liabilities | 10.7M | 21.5M | 18.4M | 9.3M | 7.5M | 10.9M | |
Total Stockholder Equity | 68.5M | 37.5M | 48.6M | 31.2M | 88.7M | 93.2M | |
Net Debt | (30.1M) | (22.8M) | (41.9M) | (31.3M) | (30.4M) | (31.9M) | |
Retained Earnings | (184.3M) | (566.2M) | (639.5M) | (662.7M) | (691.3M) | (656.8M) | |
Accounts Payable | 3.8M | 4.8M | 6.5M | 2.4M | 1.7M | 3.3M | |
Cash | 30.8M | 57.6M | 42.3M | 30.9M | 30.6M | 36.6M | |
Cash And Short Term Investments | 136.3M | 76.9M | 58.6M | 42.3M | 93.3M | 70.3M | |
Common Stock Shares Outstanding | 471.4K | 1.8M | 2.9M | 3.2M | 10.3M | 10.8M | |
Liabilities And Stockholders Equity | 79.2M | 93.7M | 67.0M | 40.8M | 97.7M | 82.0M | |
Non Current Liabilities Total | 34.3M | 34.8M | 6.9M | 211K | 1.4M | 1.3M | |
Other Current Assets | 1.4M | 4.6M | 6.1M | 7.2M | 2.7M | 3.6M | |
Other Stockholder Equity | 252.8M | 603.7M | 688.2M | 692.3M | 780.0M | 819.0M | |
Total Liab | 10.7M | 56.2M | 18.4M | 9.6M | 9.0M | 8.5M | |
Total Current Assets | 78.3M | 87.3M | 63.2M | 38.3M | 96.0M | 78.4M | |
Other Liab | 1.4M | 1.1M | 880K | 769K | 884.4K | 997.5K | |
Net Tangible Assets | 17.6M | 37.5M | 48.6M | 31.2M | 28.1M | 48.6M | |
Property Plant And Equipment Net | 769K | 2.1M | 354K | 282K | 207K | 196.7K | |
Non Current Assets Total | 842K | 6.5M | 3.9M | 2.5M | 1.7M | 2.9M | |
Non Currrent Assets Other | 73K | 4.3M | 3.5M | 2.2M | 1.5M | 1.6M | |
Other Assets | 744K | 4.9M | 3.5M | 2.5M | 2.9M | 1.9M | |
Net Receivables | 135K | 15.8M | 7.6M | 5.2M | 5.9M | 5.3M | |
Short Term Investments | 86.7M | 46.2M | 1.0M | 0.0 | 62.6M | 65.8M | |
Property Plant And Equipment Gross | 98K | 2.1M | 354K | 0.0 | 207K | 412.2K | |
Accumulated Other Comprehensive Income | (51K) | (96K) | 24K | 26K | 29.9K | 31.4K | |
Non Current Liabilities Other | 22K | 7K | 457K | 1.3M | 1.5M | 1.6M | |
Property Plant Equipment | 2.2M | 4.6M | 2.1M | 354K | 318.6K | 302.7K | |
Net Invested Capital | 68.5M | 70.7M | 48.6M | 31.2M | 88.7M | 59.9M | |
Net Working Capital | 67.7M | 65.8M | 44.8M | 28.9M | 88.4M | 55.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vyne Therapeutics is a strong investment it is important to analyze Vyne Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vyne Therapeutics' future performance. For an informed investment choice regarding Vyne Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vyne Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Vyne Stock refer to our How to Trade Vyne Stock guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vyne Therapeutics. If investors know Vyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vyne Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 1.72 | Revenue Per Share 0.016 | Quarterly Revenue Growth 0.467 | Return On Assets (0.35) | Return On Equity (0.60) |
The market value of Vyne Therapeutics is measured differently than its book value, which is the value of Vyne that is recorded on the company's balance sheet. Investors also form their own opinion of Vyne Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Vyne Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vyne Therapeutics' market value can be influenced by many factors that don't directly affect Vyne Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vyne Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vyne Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vyne Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.